GlassScriptPhysician profile
Mariana De Jongh-Beyer
NPI 1609089853
$88,631.36
in general payments reported to CMS, 2019-2025
14 companies · $12K in 2025
The $12K reported for 2025 was more than what 93% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,177 · 2020: $14K · 2021: $5,265 · 2022: $4,783 · 2023: $16K · 2024: $32K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $49K · Consulting Fee: $9,800 · Travel and Lodging: $862 · Food and Beverage: $843.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $48,750.00 |
| Consulting Fee | $9,800.00 |
| Travel and Lodging | $862.43 |
| Food and Beverage | $843.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $69,580.23 | 2021-2025 | Interstim, Gi Genius |
| Medtronic USA, INC. | $18,088.23 | 2019-2020 | |
| Abbvie INC. | $347.24 | 2019-2024 | Rinvoq, Skyrizi |
| Braintree Laboratories, INC. | $159.96 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $133.14 | 2021 | |
| Abiomed | $93.75 | 2023 | Impella |
| Celgene Corporation | $71.42 | 2021-2023 | |
| Nestle Healthcare Nutrition INC. | $48.37 | 2022 | |
| Pharming Healthcare, INC. | $38.35 | 2020-2023 | Ruconest |
| Ironwood Pharmaceuticals, INC | $18.55 | 2021 | |
| Intercept Pharmaceuticals, INC. | $16.51 | 2020 | |
| Pfizer INC. | $13.98 | 2019 | |
| Phathom Pharmaceuticals, INC. | $13.91 | 2024 | Voquezna |
| Thd America, INC. | $7.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mariana De Jongh-Beyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.